Expression of Transforming Growth Factor Beta is Elevated in Human and Experimental Diabetic Nephropathy

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1993 Mar 1

PMID 7680480

Citations 219

Authors

T Yamamoto

T Nakamura

N A Noble

E Ruoslahti

W A Border

Affiliations

Soon will be listed here.

Abstract

Diabetes is now the most common cause of progressive kidney failure leading to dialysis or transplantation. The central pathological feature of diabetic nephropathy is accumulation of extracellular matrix within the glomeruli. The factors in the diabetic milieu responsible for extracellular matrix accumulation are not understood. Here we report that in glomeruli of rats made diabetic there is a slow, progressive increase in the expression of transforming growth factor beta (TGF-beta) mRNA and TGF-beta protein. A key action of TGF-beta is induction of extracellular matrix production, and specific matrix proteins known to be induced by TGF-beta were increased in diabetic rat glomeruli. These proteins include an alternatively spliced form of fibronectin, tenascin, and the proteoglycan biglycan. TGF-beta has not previously been implicated in the matrix accumulation that occurs in the diabetic kidney. Glomeruli from humans with diabetic nephropathy also showed a striking increase in immunoreactive TGF-beta protein and deposition of the special form of fibronectin, whereas glomeruli from normal subjects or from individuals with other glomerular diseases (where extracellular matrix accumulation is not a feature) were negative or barely positive. These results implicate TGF-beta in the pathogenesis of diabetic nephropathy.

Citing Articles

Induced Genetic Deletion of Cell Division Autoantigen 1 in Adulthood Attenuates Diabetes-Associated Renal Fibrosis.

Huynh P, Yang Y, Tian H, Wu T, Huang M, Tang J Int J Mol Sci. 2025; 26(5).

PMID: 40076647 PMC: 11900456. DOI: 10.3390/ijms26052022.

Modulation of TGF-β signaling new approaches toward kidney disease and fibrosis therapy.

Hong Q, Kim H, Cai G, Chen X, He J, Lee K Int J Biol Sci. 2025; 21(4):1649-1665.

PMID: 39990662 PMC: 11844295. DOI: 10.7150/ijbs.101548.

Imeglimin for Type 2 Diabetes Mellitus: Its Efficacy and Insight Into the Potential Benefit for Renal and Liver Function.

Uto A, Ishinoda Y, Asaga T, Tanahashi Y, Kobayashi A, Meshino H Cureus. 2024; 16(8):e66322.

PMID: 39238763 PMC: 11377120. DOI: 10.7759/cureus.66322.

Targeting the transmembrane cytokine co-receptor neuropilin-1 in distal tubules improves renal injury and fibrosis.

Li Y, Wang Z, Xu H, Hong Y, Shi M, Hu B Nat Commun. 2024; 15(1):5731.

PMID: 38977708 PMC: 11231174. DOI: 10.1038/s41467-024-50121-6.

Intrinsic TGF-β signaling attenuates proximal tubule mitochondrial injury and inflammation in chronic kidney disease.

Kayhan M, Vouillamoz J, Gonzalez Rodriguez D, Bugarski M, Mitamura Y, Gschwend J Nat Commun. 2023; 14(1):3236.

PMID: 37270534 PMC: 10239443. DOI: 10.1038/s41467-023-39050-y.

References

Derynck R, Jarrett J, Chen E, Goeddel D . The murine transforming growth factor-beta precursor. J Biol Chem. 1986; 261(10):4377-9. View

Bassols A, Massague J . Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J Biol Chem. 1988; 263(6):3039-45. View

Lee C, MAUER S, Brown D, Sutherland D, Michael A, Najarian J . Renal transplantation in diabetes mellitus in rats. J Exp Med. 1974; 139(4):793-800. PMC: 2139572. DOI: 10.1084/jem.139.4.793. View

Weil 3rd R, Nozawa M, Koss M, Weber C, REEMTSMA K, McIntosh R . Pancreatic transplantation in diabetic rats: renal function, morphology, ultrastructure, and immunohistology. Surgery. 1975; 78(2):142-8. View

MAUER S, Steffes M, Michael A, Brown D . Studies of diabetic nephropathy in animals and man. Diabetes. 1976; 25(2 SUPPL):850-7. View

MAUER S, Barbosa J, Vernier R, Kjellstrand C, Buselmeier T, Simmons R . Development of diabetic vascular lesions in normal kidneys transplanted into patients with diabetes mellitus. N Engl J Med. 1976; 295(17):916-20. DOI: 10.1056/NEJM197610212951703. View

MAUER S, Steffes M, Brown D . Animal models of diabetic nephropathy. Adv Nephrol Necker Hosp. 1979; 8:23-42. View

Steffes M, Brown D, Basgen J, MAUER S . Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats. Diabetes. 1980; 29(7):509-15. DOI: 10.2337/diab.29.7.509. View

Sporn M, Roberts A, Shull J, Smith J, Ward J, Sodek J . Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science. 1983; 219(4590):1329-31. DOI: 10.1126/science.6572416. View

10.

Dorman J, LaPorte R, Kuller L, Cruickshanks K, Orchard T, Wagener D . The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes. 1984; 33(3):271-6. DOI: 10.2337/diab.33.3.271. View

11.

MAUER S, Steffes M, Ellis E, Sutherland D, Brown D, Goetz F . Structural-functional relationships in diabetic nephropathy. J Clin Invest. 1984; 74(4):1143-55. PMC: 425280. DOI: 10.1172/JCI111523. View

12.

Fort P, Marty L, Piechaczyk M, el Sabrouty S, Dani C, Jeanteur P . Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985; 13(5):1431-42. PMC: 341087. DOI: 10.1093/nar/13.5.1431. View

13.

Zatz R, Meyer T, Rennke H, Brenner B . Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A. 1985; 82(17):5963-7. PMC: 390674. DOI: 10.1073/pnas.82.17.5963. View

14.

Ignotz R, Massague J . Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem. 1986; 261(9):4337-45. View

15.

Kehrl J, Wakefield L, Roberts A, Jakowlew S, Alvarez-Mon M, Derynck R . Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986; 163(5):1037-50. PMC: 2188095. DOI: 10.1084/jem.163.5.1037. View

16.

Roberts A, Sporn M, Assoian R, Smith J, Roche N, Wakefield L . Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986; 83(12):4167-71. PMC: 323692. DOI: 10.1073/pnas.83.12.4167. View

17.

RISTOW H . BSC-1 growth inhibitor/type beta transforming growth factor is a strong inhibitor of thymocyte proliferation. Proc Natl Acad Sci U S A. 1986; 83(15):5531-3. PMC: 386321. DOI: 10.1073/pnas.83.15.5531. View

18.

Postlethwaite A, Keski-Oja J, Moses H, Kang A . Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med. 1987; 165(1):251-6. PMC: 2188256. DOI: 10.1084/jem.165.1.251. View

19.

Wahl S, Hunt D, Wakefield L, McCartney-Francis N, Wahl L, Roberts A . Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A. 1987; 84(16):5788-92. PMC: 298948. DOI: 10.1073/pnas.84.16.5788. View

20.

Edwards D, Murphy G, Reynolds J, Whitham S, Docherty A, Angel P . Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987; 6(7):1899-904. PMC: 553574. DOI: 10.1002/j.1460-2075.1987.tb02449.x. View